Products with
Hepatoprotective bioactivity
Cat.No.
|
Product Name
|
BCN1418 |
Soyasaponin II
|
1. Soyasaponin II has antiviral effects, it can inhibit the replication of human cytomegalovirus, influenza virus, and human immunodeficiency virus type 1.
2. Soyasaponins II can inhibit the conversion of fibrinogen to fibrin, it also can promote activation of the fibrinolytic system in a plasminogen-containing fibrin plate.
3. Soyasaponin II has hepatoprotective actions towards immunologically induced liver injury on primary cultured rat hepatocytes.
4. Soyasaponins are a potential antitumor compound and the apoptosis induced by soyasaponins is a key antitumor mechanism. |
BCN1433 |
Soyasapogenol A
|
1. Soyasapogenol A and soyasapogenol B concentrated extracts show a greater ability to inhibit proliferation of cultured Hep-G2 when compared to a total soyasaponin extract that did not contain any soyasapogenols.
2. Soyasapogenol A directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model.
3. Soyasapogenol A shows estrogenic activities. |
BCN1627 |
Soyasaponin IV
|
1. Soyasaponin IV has hepatoprotective activity.
2. Soyasaponin IV has antimutagenic activity in mammalian cells. |
BCN1655 |
6-O-(3'',4''-Dimethoxycinnamoyl)catalpol
|
1. 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol has anti-hepatotoxic activity. |
BCN2096 |
Caftaric acid
|
Caftaric acid is an inhibitor of the protein-protein interactions mediated by the Src-family kinases, which has anti-mutagenicity. Caftaric acid is the major dietary polyphenol present in various foods, it before methamphetamine injections can prevent liver toxicity and oxidative stress. |